Avraham Bayer1, Nicholas J Lennemann2, Yingshi Ouyang1, Elena Sadovsky3, Megan A Sheridan4, R Michael Roberts4, Carolyn B Coyne5, Yoel Sadovsky6. 1. Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Obstetrics and Gynecology, and Reproductive Science, University of Pittsburgh, PA 15213, USA. 2. Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA 15219, USA. 3. Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA. 4. Division of Animal Sciences and Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA; Department of Biochemistry and Bond Life Sciences Center, University of Missouri, Columbia, MO 65211, USA. 5. Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Obstetrics and Gynecology, and Reproductive Science, University of Pittsburgh, PA 15213, USA; Department of Pediatrics, University of Pittsburgh, Pittsburgh, PA 15219, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA. 6. Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, PA 15213, USA; Department of Obstetrics and Gynecology, and Reproductive Science, University of Pittsburgh, PA 15213, USA; Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA 15219, USA. Electronic address: ysadovsky@mwri.magee.edu.
Abstract
INTRODUCTION: Cultured primary human trophoblasts (PHT), derived from term placentas, are relatively resistant to infection by diverse viruses. The resistance can be conferred to non-trophoblastic cells by pre-exposing them to medium that was conditioned by PHT cells. This antiviral effect is mediated, at least in part, by microRNAs (miRNA) expressed from the chromosome 19 microRNA cluster (C19MC). Recently we showed that PHT cells and cells pre-exposed to PHT medium are also resistant to infection by Zika virus (ZIKV), an effect mediated by the constitutive release of the type III interferons (IFN) IFN lambda-1 and IFN lambda-2 in trophoblastic medium. We hypothesized that trophoblastic C19MC miRNA are active against ZIKV, and assessed the interaction of this pathway with IFN lambda-1 - mediated resistance. METHODS: Term PHT cells were cultured using standard techniques. An osteosarcoma cell line (U2OS) was used as non-trophoblastic cells, which were infected with either ZIKV or vesicular stomatitis virus (VSV). Trophoblastic extracellular vesicles (EVs) were produced by gradient ultracentrifugation. RT-qPCR was used to determine viral infection, cellular or medium miRNA levels and the expression of interferon-stimulated genes. RESULTS: We showed that C19MC miRNA attenuate infection of U2OS cells by ZIKV, and that C19MC miRNA or exosomes that contain C19MC miRNA did not influence the type III IFN pathway. Similarly, cell exposure to recombinant IFN lambda-1 had no effect on miRNA expression, and these pathways did not exhibit synergistic interaction. DISCUSSION: PHT cells exert antiviral activity by at least two independent mechanisms, mediated by C19MC miRNA and by type III IFNs.
INTRODUCTION: Cultured primary human trophoblasts (PHT), derived from term placentas, are relatively resistant to infection by diverse viruses. The resistance can be conferred to non-trophoblastic cells by pre-exposing them to medium that was conditioned by PHT cells. This antiviral effect is mediated, at least in part, by microRNAs (miRNA) expressed from the chromosome 19 microRNA cluster (C19MC). Recently we showed that PHT cells and cells pre-exposed to PHT medium are also resistant to infection by Zika virus (ZIKV), an effect mediated by the constitutive release of the type III interferons (IFN) IFN lambda-1 and IFN lambda-2 in trophoblastic medium. We hypothesized that trophoblastic C19MC miRNA are active against ZIKV, and assessed the interaction of this pathway with IFN lambda-1 - mediated resistance. METHODS: Term PHT cells were cultured using standard techniques. An osteosarcoma cell line (U2OS) was used as non-trophoblastic cells, which were infected with either ZIKV or vesicular stomatitis virus (VSV). Trophoblastic extracellular vesicles (EVs) were produced by gradient ultracentrifugation. RT-qPCR was used to determine viral infection, cellular or medium miRNA levels and the expression of interferon-stimulated genes. RESULTS: We showed that C19MC miRNA attenuate infection of U2OS cells by ZIKV, and that C19MC miRNA or exosomes that contain C19MC miRNA did not influence the type III IFN pathway. Similarly, cell exposure to recombinant IFN lambda-1 had no effect on miRNA expression, and these pathways did not exhibit synergistic interaction. DISCUSSION: PHT cells exert antiviral activity by at least two independent mechanisms, mediated by C19MC miRNA and by type III IFNs.
Authors: Yingshi Ouyang; Avraham Bayer; Tianjiao Chu; Vladimir A Tyurin; Valerian E Kagan; Adrian E Morelli; Carolyn B Coyne; Yoel Sadovsky Journal: Placenta Date: 2016-09-14 Impact factor: 3.481
Authors: Kjersti M Aagaard; Anismrita Lahon; Melissa A Suter; Ravi P Arya; Maxim D Seferovic; Megan B Vogt; Min Hu; Fabio Stossi; Michael A Mancini; R Alan Harris; Maike Kahr; Catherine Eppes; Martha Rac; Michael A Belfort; Chun Shik Park; Daniel Lacorazza; Rebecca Rico-Hesse Journal: Sci Rep Date: 2017-01-27 Impact factor: 4.379
Authors: Meghan S Vermillion; Jun Lei; Yahya Shabi; Victoria K Baxter; Nathan P Crilly; Michael McLane; Diane E Griffin; Andrew Pekosz; Sabra L Klein; Irina Burd Journal: Nat Commun Date: 2017-02-21 Impact factor: 14.919
Authors: Gabriella Pequeno Costa Gomes de Aguiar; Claudio Manuel Gonçalves da Silva Leite; Beatriz Dias; Silvania Maria Mendes Vasconcelos; Renata Amaral de Moraes; Maria Elisabete Amaral de Moraes; Antonio Carlos Rosario Vallinoto; Danielle Silveira Macedo; Luciano Pamplona de Goes Cavalcanti; Fabio Miyajima Journal: Front Immunol Date: 2019-05-31 Impact factor: 7.561
Authors: Amy E Braun; Kristin L Muench; Beatriz G Robinson; Angela Wang; Theo D Palmer; Virginia D Winn Journal: Reprod Sci Date: 2020-11-04 Impact factor: 3.060
Authors: Nihal A Salem; Amanda H Mahnke; Alan B Wells; Alexander M Tseng; Lyubov Yevtushok; Natalya Zymak-Zakutnya; Wladimir Wertlecki; Christina D Chambers; Rajesh C Miranda Journal: Biol Sex Differ Date: 2020-09-10 Impact factor: 5.027